Medicofarma Biotech SA (WSE: MDB)

Market Cap	24.47M
Revenue (ttm)	1.07M
Net Income (ttm)	-3.17M
Shares Out	67.98M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,471
Average Volume	26,013
Open	0.360
Previous Close	0.360
Day's Range	0.350 - 0.367
52-Week Range	0.330 - 1.195
Beta	3.20
RSI	39.02
Earnings Date	Feb 4, 2025

About Medicofarma Biotech

Medicofarma Biotech SA, a biotechnology company, provides medicines, medicinal products, and biotechnology products. The company is involved in the research and development works in collaboration with pharmaceutical and cosmetic manufacturing plants, as well as research units. It also offers staff support and equipment during the early stages of development of generic pharmaceutical products and cosmetics; and covid-19 test kits, such as real time PCR genetic tests. The company was formerly known as Inbook Spólka Akcyjna. Medicofarma Biotech SA...

• Industry: Biotechnology & Medical Research
• Sector: Healthcare
• Founded: 2001
• Employees: 20
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: MDB

Financial Performance

In 2023, Medicofarma Biotech's revenue was 750,809, a decrease of -82.34% compared to the previous year's 4.25 million. Losses were -3.44 million, 116.4% more than in 2022.